REPORT ID 14071

Global Ocular Drug Delivery Market Research Report 2017

Publish Date
23-Nov-17
Pages
105
Format
Electronic (PDF)

In this report, the global Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ocular Drug Delivery in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Ocular Drug Delivery market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    OCULAR THERAPEUTIX, INC
    Alimera Sciences
    Allergan, Plc
    EyeGate Pharma
    Valeant Pharmaceuticals International, Inc
    Envisia Therapeutics
    Clearside Biomedical
    Graybug Vision Inc
    Taiwan Liposome Company
    Santen Pharmaceutical Co., Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Technology
        Ocular Insert
        Iontophoresis
        Intraocular Implants
        In Situ Gel & Punctal Plugs
        Others
    By Form
        Solution
        Suspension
        Emulsion
        Liposomes & Nanoparticles
        Ointment
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Ambulatory Surgical Centers
    Ophthalmic Clinics
    Homecare Settings

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Ocular Drug Delivery Market Research Report 2017
1 Ocular Drug Delivery Market Overview
    1.1 Product Overview and Scope of Ocular Drug Delivery
    1.2 Ocular Drug Delivery Segment By Technology
        1.2.1 Global Ocular Drug Delivery Production and CAGR (%) Comparison By Technology (Product Category)(2012-2022)
        1.2.2 Global Ocular Drug Delivery Production Market Share By Technology (Product Category) in 2016
        1.2.3 Ocular Insert
        1.2.4 Iontophoresis
        1.2.5 Intraocular Implants
        1.2.6 In Situ Gel & Punctal Plugs
        1.2.7 Others
    1.3 Ocular Drug Delivery Segment By Form
        1.3.1 Solution
        1.3.2 Suspension
        1.3.3 Emulsion
        1.3.4 Liposomes & Nanoparticles
        1.3.5 Ointment
    1.4 Global Ocular Drug Delivery Segment by Application
        1.4.1 Ocular Drug Delivery Consumption (Sales) Comparison by Application (2012-2022)
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Centers
        1.4.4 Ophthalmic Clinics
        1.4.5 Homecare Settings
    1.5 Global Ocular Drug Delivery Market by Region (2012-2022)
        1.5.1 Global Ocular Drug Delivery Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.5.2 North America Status and Prospect (2012-2022)
        1.5.3 Europe Status and Prospect (2012-2022)
        1.5.4 China Status and Prospect (2012-2022)
        1.5.5 Japan Status and Prospect (2012-2022)
        1.5.6 Southeast Asia Status and Prospect (2012-2022)
        1.5.7 India Status and Prospect (2012-2022)
    1.6 Global Market Size (Value) of Ocular Drug Delivery (2012-2022)
        1.6.1 Global Ocular Drug Delivery Revenue Status and Outlook (2012-2022)
        1.6.2 Global Ocular Drug Delivery Capacity, Production Status and Outlook (2012-2022)

2 Global Ocular Drug Delivery Market Competition by Manufacturers
    2.1 Global Ocular Drug Delivery Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Ocular Drug Delivery Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Ocular Drug Delivery Production and Share by Manufacturers (2012-2017)
    2.2 Global Ocular Drug Delivery Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Ocular Drug Delivery Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Ocular Drug Delivery Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Ocular Drug Delivery Market Competitive Situation and Trends
        2.5.1 Ocular Drug Delivery Market Concentration Rate
        2.5.2 Ocular Drug Delivery Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Ocular Drug Delivery Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Ocular Drug Delivery Capacity and Market Share by Region (2012-2017)
    3.2 Global Ocular Drug Delivery Production and Market Share by Region (2012-2017)
    3.3 Global Ocular Drug Delivery Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Ocular Drug Delivery Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Ocular Drug Delivery Consumption by Region (2012-2017)
    4.2 North America Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
    4.4 China Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)
    4.7 India Ocular Drug Delivery Production, Consumption, Export, Import (2012-2017)

5 Global Ocular Drug Delivery Production, Revenue (Value), Price Trend by Type
    5.1 Global Ocular Drug Delivery Production and Market Share by Type (2012-2017)
    5.2 Global Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
    5.3 Global Ocular Drug Delivery Price by Type (2012-2017)
    5.4 Global Ocular Drug Delivery Production Growth by Type (2012-2017)

6 Global Ocular Drug Delivery Market Analysis by Application
    6.1 Global Ocular Drug Delivery Consumption and Market Share by Application (2012-2017)
    6.2 Global Ocular Drug Delivery Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Ocular Drug Delivery Manufacturers Profiles/Analysis
    7.1 OCULAR THERAPEUTIX, INC
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Ocular Drug Delivery Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Alimera Sciences
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Ocular Drug Delivery Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Alimera Sciences Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Allergan, Plc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Ocular Drug Delivery Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Allergan, Plc Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 EyeGate Pharma
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Ocular Drug Delivery Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 EyeGate Pharma Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Valeant Pharmaceuticals International, Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Ocular Drug Delivery Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Envisia Therapeutics
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Ocular Drug Delivery Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Envisia Therapeutics Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Clearside Biomedical
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Ocular Drug Delivery Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Clearside Biomedical Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Graybug Vision Inc
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Ocular Drug Delivery Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Graybug Vision Inc Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Taiwan Liposome Company
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Ocular Drug Delivery Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Taiwan Liposome Company Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Santen Pharmaceutical Co., Ltd
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Ocular Drug Delivery Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Ocular Drug Delivery Manufacturing Cost Analysis
    8.1 Ocular Drug Delivery Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Ocular Drug Delivery

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Ocular Drug Delivery Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Ocular Drug Delivery Market Forecast (2017-2022)
    12.1 Global Ocular Drug Delivery Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Ocular Drug Delivery Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Ocular Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Ocular Drug Delivery Price and Trend Forecast (2017-2022)
    12.2 Global Ocular Drug Delivery Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Ocular Drug Delivery Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Ocular Drug Delivery Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Ocular Drug Delivery Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer